Research and development of therapeutic antibodies
To pursue further advancement of antibody technologies, Kyowa Kirin continues to take on various challenges. Through drug discoveries that make the most of our diverse modality and unique strengths, we continue to investigate diseases for which effective cures have yet to be discovered.
Kyowa Kirin’s Antibody Technology
Typical antibody technologies include “bispecific antibody technology REGULGENT™” which exerts a powerful effect on targeted tissues and cells by binding to two types of antigens, “antibody-enhancing technology POTELLIGENT®” which has high ADCC activity, and “fully human antibody production technology” which makes the same human antibodies by transgenic mice.
Kyowa Kirin’s Research and Development
Kyowa Kirin mobilizes cutting-edge biotechnology centered on antibody engineering technology to pursue research on disease science in our areas of focus, which include nephrology, oncology, immunology & allergy, and neurology. We strive for the creation of new medical value and the advancement of discoveries in drugs.
Kyowa Kirin’s Production Technology
We are working on establishing world-class production technology for biopharmaceuticals including therapeutic antibodies.
Aiming to continuously create life-changing value that brings happiness and hope to people who face illness.